V-Wave
Diana Sanderson is the President of Sanderson Clinical Consulting, Inc. Diana has extensive experience as a Contract Monitor in various healthcare companies such as V-Wave, LivaNova, Edwards Lifesciences, CAISSON INTERVENTIONAL LLC, 4TECH Inc., Mallinckrodt Pharmaceuticals, genae, and SoundBite Medical Solutions Inc. Additionally, Diana has served as the Head of Clinical Investigations at OMsignal. Diana holds a Master's Degree in Human/Medical Genetics from Sarah Lawrence College and a Bachelor's Degree in Molecular Biology from McGill University.
This person is not in any offices
V-Wave
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.